Treatment of recurrent malignant gliomas with chronic oral high-dose tamoxifen. Damek, D.M. and F.H. Hochberg. Clinical aspects of brain tumor. L.A. Wetmore, A. Leyva, and G. Schwartsmann. DeMattia, J.A., W. Zhang, and W.T. Couldwell. .
Tyrosine kinase inhibitors - potential for the treatment of primary brain tumours.
M.D. Weil, and N.K. Foreman. Tamoxifen radiosensitization in human glioblastoma cell lines. Ducharme, J., K. Fried, G. Shenouda, B. Leyland-Jones, and I.W. Wainer. Tamoxifen metabolic patterns within a glioma patient population treated with high-dose tamoxifen. P.Y. Liu, M.S. Mitchell, W.S. Fletcher, Walker, MJ, J.W. Goodwin, R.L. Stephens, and V.K. Sondak.